<qa>  What is the name of the female partner who is sterile or agrees to use hormonal8. Male patients will either be surgically sterile or agree to use, from the time of Check-in Day -1 until 90 days following the last dose of study drug, the following forms of contraception: male condom with spermicide and a female partner who is sterile or agrees to use hormonal contraceptives, female condom with spermicide, diaphragm or cervical cap with spermicide, intrauterine device, oral, implantable, or injectable contraceptives. Male patients will refrain from sperm donation from the time of Check-in Day -1 until 90 days following the last dose of study drug. 